Description

Conditions or diseases: *Collagenoses, connective tissue diseases: -Evolving flare-ups of systemic diseases, including: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis. *Dermatological: -Severe autoimmune bullous dermatoses, particularly pemphigus and bullous pemphigoid. Severe forms of infant angiomas. -Certain forms of lichen planus. -Certain acute urticarias. -Severe forms of neutrophilic dermatoses. *Digestive: -Evolving flare-ups of ulcerative colitis and Crohn’s disease. -Chronic active autoimmune hepatitis (with or without cirrhosis). -Severe acute alcoholic hepatitis, histologically proven. *Endocrine: -Severe subacute de Quervain’s thyroiditis. -Certain hypercalcemias. *Hematological: -Severe immunological thrombocytopenic purpuras. -Autoimmune hemolytic anemias. -In association with various chemotherapies in the treatment of lymphoid malignancies. -Chronic, acquired or congenital erythroblastopenias. *Infectious: -Tuberculous pericarditis and severe forms of tuberculosis that are life-threatening. -Pneumocystis carinii pneumonia with severe hypoxia. *Neoplastic: -Antiemetic treatment during antineoplastic chemotherapy. -Edematous and inflammatory flare-up associated with antineoplastic treatments (radio and chemotherapy). *Nephrological: -Nephrotic syndrome with minimal glomerular lesions. -Nephrotic syndrome of primary segmental and focal hyalinosis. -Stages III and IV of lupus nephropathy. -Intrarenal granulomatous sarcoidosis. -Vasculitis with renal involvement. -Primary extracapillary glomerulonephritis. *Neurological: -Myasthenia gravis, cerebral edema of tumoral cause. -Chronic, idiopathic, inflammatory polyradiculoneuropathy. -Infantile spasm (West syndrome), Lennox-Gastaut syndrome. -Multiple sclerosis in flare-up, following intravenous corticosteroid therapy. *Ophthalmological: -Severe anterior and posterior uveitis. -Oedematous exophthalmos. -Certain optic neuropathies, following intravenous corticosteroid therapy (in this indication, the oral route as first-line treatment is not recommended). *ENT: -Certain serous otitis. -Nasosinusal polyposis. -Certain acute or chronic sinusitis. -Seasonal allergic rhinitis in short-term treatment. -Acute stridulous laryngitis (subglottic laryngitis) in children. *Respiratory: -Persistent asthma preferably in short-term treatment in case of failure of high-dose inhaled treatment. -Exacerbations of asthma, in particular severe acute asthma. -Chronic obstructive pulmonary disease in assessment of the reversibility of the obstructive syndrome. -Progressive sarcoidosis. -Diffuse interstitial pulmonary fibrosis. *Rheumatological: -Rheumatoid arthritis and certain polyarthritis. -Pseudopolyarthritis rheumatica and Horton’s disease. Acute articular rheumatism. -Severe and rebellious cervicobrachial neuralgia. *Allogeneic organ and hematopoietic stem cell transplantation: -Prophylaxis or treatment of graft rejection. -Prophylaxis or treatment of graft-versus-host disease.